Ionising radiation and cancer risks: What have we learned from epidemiology?

International Journal of Radiation Biology

Volumn 85, Issue 6, 2009, Pages 467-482

  Gilbert, Ethel S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer risks; Dose response; Epidemiology; Ionising radiation

Indexed keywords

IODINE 131; RADON;

ADULT; ARTICLE; ATOMIC BOMB; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENICITY; COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; EPIDEMIC; FEMALE; HUMAN; IONIZING RADIATION; LEUKEMIA; LINEAR ENERGY TRANSFER; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; SOLID TUMOR;

ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC STUDIES; HUMANS; NEOPLASMS; RADIATION INJURIES; RISK;

EID: 67651250815     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000902883836     Document Type: Article

References (104)

1. Astakhova LN, Anspaugh LR, Beebe GW, Bouville A, Drozdovitch VV, Garber V, Gavrilin YI, Khrouch VT, Kuvshinnikov AV, Kuzmenkov YN, Minenko VP, Moschik KV, Nalivko AS, Robbins J, Shemiakina EV, Shinkarev S, Tochitskaya SI, Waclawiw MA. 1998. Chernobyl-related thyroid cancer in children in Belarus: A case-control study. Radiation Research 150:349-356.
2. Bithell JF. 1989. Epidemiologic studies of children irradiated in utero. In: Baverstock KF, Stather JW, editors. Low dose radiation: biological bases of risk assessment. London: Taylor & Francis; 1989. pp 77-87.
3. Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD Jr, Berkowitz GS, Gatti RA, Teitelbaum, Smith SA, Rosenstein BS, Borresen-Dale, AL, Concannon P, Thompson WD. 2004. Study design: Evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Research 6:R199-214.
4. Boice JD Jr. 2006. Ionizing radiation. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; pp 259-293.
5. Boice JD Jr, Blettner M, Kleinerman RA, Stovall M, Moloney WCC, Engholm G, Austin DF, Bosch AA, Cookfair DL, Krementz ET, Latourette HB, Peters LJ, Schulz MD, Lundell M, Pettersson, Storm H, Bell J, Coleman MP, Fraser P, Palmer M, Prior P, Choi NW, Hilsop TG, Kock M, Robb D, Robson D, Spengler RF, von Fournier M, Frischkorn R, Lochmuller H, Pompe-Kirn V, Rimpela A, Kjorstad M, Pejovic H, Sigurdson
6. K, Pisani P, Kucera H, Hutchison GB. 1987. Radiation dose and leukemia risk in patients treated for cancer of the cervix. Journal of the National Cancer Institute 79(6):1295-1311.
7. Boice JD Jr, Harvey EB, Blettner M, Stovall M, Flannery JT. 1992. Cancer in the contralateral breast after radiotherapy for breast cancer. New England Journal of Medicine 326(12):781-785.
8. Boice JD, Miller RW. 1999. Childhood and adult cancer after intra-uterine exposure to ionizing radiation. Teratology 59:227-233.
9. Breslow NE, Day NE. 1980. Statistical methods in cancer research. Volume I. The analysis of case-control studies. Lyon, France: IARC Sci Publ 32.
10. Cardis E, Gilbert ES, Carpenter L, Howe G, Kato I, Armstrong BK, Beral V, Cowper G, Douglas A, Fix J, Fry SA, Kaldor J, Lave C, Salmon L, Smith PG, Voelz GL, Wiggs LD. 1995. Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiation Research 142:117-132.
11. 131I in childhood. Journal of the National Cancer Institute 97(10): 724-732.
12. Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kalor J, Muirhead CR, Scubauer-Berigan M, Yoshimura T, Bermann F, Cowper G, Fix J, Hacker C, Heinmiller B, Marshall M, Thierry-Chef I, Utterback D, Ahn Y-O, Amoros E, Ashmore P, Auvinen A, Bae J-M, Bernar Soloano J, Biau A, Combalot E, Deboodt P, Diea Sacristan A, Eklof M, Engels H, Enghold G, Gulis G, Habib R, Holan K, Hyvonen H, Kerekes A, Kurtinaitis J, Malker H, Martuzzi M, Mastauskas A, Monnet A, Moser M, Pearce MS, Richardson DB, Rodrigues-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M and Veress K. 2005a. Risk of cancer after low doses of ionizing radiation: retrospective cohort study in 15 countries. British Medical Journal 331:77-82.
13. Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kalor J, Muirhead CR, Scubauer-Berigan M, Yoshimura T, Bermann F, Cowper G, Fix J, Hacker C, Heinmiller B, Marshall M, Thierry-Chef I, Utterback D, Ahn Y-O, Amoros E, Ashmore P, Auvinen A, Bae J-M, Bernar Soloano J, Biau A, Combalot E, Deboodt P, Diea Sacristan A, Eklof M, Engels H, Enghold G, Gulis G, Habib R, Holan K, Hyvonen H, Kerekes A, Kurtinaitis J, Malker H, Martuzzi M, Mastauskas A, Monnet A, Moser M, Pearce MS, Richardson DB, Rodrigues-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M, Veress K. 2007. The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: Estimates of radiation related cancer risks. Radiation Research 167:396-416.
14. Carpenter L, Higgins C, Douglas A, Fraser P, Beral V, Smith P. 1994. Combined analysis of mortality in three United Kingdom nuclear industry workforces, 1946-1988. Radiation Research 138:224-238.
15. Carr ZA, Kleinerman RA, Stovall M, Weinstock RM, Griem ML, Land CL. 2002. Malignant neoplasms after radiation therapy for peptic ulcer. Radiation Research 157:668-677.
16. Cologne JB, Tokuoka S, Beebe GW, Fukuhara T, Mabuchi K. 1999. Effects of radiation on incidence of primary liver cancer among atomic bomb survivors. Radiation Research 152:364-373.
17. Court-Brown WM, Doll R. 1957. Leukaemia and aplastic anaemia in patients irradiated for ankylogin sponylitis. Medical Research Council special Report Series No. 295; London: Her Majesty's Stationery Office. Now published in Journal of Radiological Protection 27:B15-154, 2007.
18. Curtis RE, Boice JD, Stovall M, Bernstein L, Greenberg RS, Greenberg RS, Flannery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN. 1992. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. New England Journal of Medicine 326:1745-1751.
19. Curtis RE, Boice JD Jr, Stovall M, Bernstein L, Holowaty E, Karjalainen S, Langmark F, Nasca PC, Schwartz AG, Schymura MJ, Storm HH, Toogood P, Weyer P, Moloney WC. 1994. Relationship of leukemia risk to radiation dose following cancer of the uterine corpus. Journal of the National Cancer Institute 86(17):1315-1323.
20. Darby SC, Hill D, Auvinen A, Barros-Dios JM, Baysson H, Bochicchio F, Deo H, Falk R, Farchi S, Figueiras A, Hakama M, Heid I, Hunter N, Kreienbrack L, Dreuzer M, Lagarde F, Makelainen I, Muirhead C, Oberaigner W, Pershagen G, Ruosteenoja E, Rosario AS, Tirmarch M, Tomasek L, Whitley E, Wichmann H-E, Doll R. 2005. Radon in homes and risk of lung cancer: Collaborative analysis of individual data from 13 European case-control studies. British Medical Journal 330:223-226.
21. Davis F, Boice J, Hrubec Z, Monson R. 1989. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Research 49:6130-6136.
22. Doll R. 1995. Hazards of ionizing radiation: 100 years of observations on man. British Journal of Cancer 72:1339-1349.
23. Doll R, Wakeford R. 1997. Risk of childhood cancer from fetal irradiation. British Journal of Radiology 70:130-139.
24. Doody MM, Freedman DM, Alexander BH, Hauptmann M, Miller JS, Rao RW, Macuchi K, Ron E, Sigurdson AJ, Linet MS. 2006. Breast cancer incidence in U.S. radiologic technologists. Cancer 106:2707-2715.
25. Folley JH, Borges W, Yamasaki T. 1952. Incidence of leukemia in survivors of the atom bomb in Hiroshima and Nagasaki, Japan. American Journal of Medicine 13:311-321.
26. Freedman DM, Sigurdson A, Rao RS, Hauptmann M, Alexander B, Mohan A, Doody MM, Linet MS. 2003. Risk of melanoma among radiologic technologists in the United States. International Journal of Cancer 103(4):556-562.
27. Gilbert ES. 2001. Invited commentary: Studies of workers exposed to low doses of radiation. American Journal of Epidemiology 153(4):319-322.
28. Gilbert ES, Cragle DL, Wiggs LD. 1993. Updated analyses of combined mortality data for workers at the Hanford Site, Oak Ridge National Laboratory, and Rocky Flats Weapons Plant. Radiation Research 136(3):408-421.
29. Gilbert ES, Stovall M, Gospodarowicz M, van Leeuwen GE, Andersson M, Glimelius B, Joensuu T, Lynch CF, Curtis RE, Boice JD Jr, Clarke EA, Travis LB. 2003. Lung cancer after treatment for Hodgkin's disease: Focus on radiation effects. Radiation Research 159(2):161-173.
30. Greenland S, Robins J. 1994. Invited commentary: Ecologic studies - biases, misconceptions, and counterexamples. American Journal of Epidemiology 139(8):747-760.
31. Guibout C, Adjadj E, Rubino C, Shamsaldin A, Grimaud E, Hawkins M, Mathieu MC, Oberlin O, Zucker JM, Panis X, Lagrange JL, Daly Schveitzer N, Chavaudra J, de Vathaire F. 2005. Malignant breast tumors after radiotherapy for a first cancer during childhood. Journal of Clinical Oncology 23:197-204.
32. Hatch M, Brenner A, Bogdanova T, Derevyanko A, Kuptsova N, Likhtarev I, Bouville A, Tereshchenko V, Kovgan L, Spak V, Ostroumova E, Greenebaum E, Zabotska L, Ron E, Tronko M. 2008. A screening study of thyroid cancer and other thyroid diseases among individuals exposed in utero to iodine-131 from Chornobyl fallout. Journal of Clinical Endocrinology and Metabolism. 94:899-906.
33. Hawkins MM, Wilson LM, Burton HS, Potok MH, Winter DL, Marsden HB, Stovall MA. 1996. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. Journal of the National Cancer Institute 88(5):270-278.
34. Hawkins MM, Wilson LM, Stovall MA, Marsden HB, Potok MH, Kingston JE, Chessells JM. 1992. Epipodophyllotoxins, alkylat-ing agents, and radiation and risk of secondary leukaemia after childhood cancer. British Medical Journal 304:951-958.
35. Hooning MJ, Aleman BMP, Hauptmann M, Baaijens MHA, Klijn JGM, Noyon R, Stovall M, van Leeuwen FE. 2008. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. Journal of Clinical Oncology 26:5561-5568.
36. Howe GR. 1995. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study. Radiation Research 142(3):295-304.
37. Inskip PD, Kleinerman RA, Stovall M, Cookfair DL, Hadjmichael O, Moloney WC, Monson RR, Thompson WD, Wactawski-Wende J, Wagoner JK, Boice JD Jr. 1993. Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease. Radiation Research 135:108-124.
38. Inskip PD, Monson RR, Wagoner JK, Stovall M, Davis FG, Kleinerman RA, Boice JD Jr. 1990. Leukemia following radiotherapy for uterine bleeding. Radiation Research 122:107-119.
39. Inskip PD, Stovall M, Flannery JT. 1994. Lung cancer risk and radiation dose among women treated for breast cancer. Journal of the National Cancer Institute 86:983-988.
40. Jacob P, Kenigsberg Y, Zvonova YI, Goulko G, Buglova E, Heidenreich WF, Golovneva A, Bratilova AA, Drozdovitch V, Kruk J, Pochtennaja GT, Balonov M, Demidchik EP, Paraetzke HG. 1999. Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. British Journal of Cancer 80(9):1461-1469.
41. Kesminiene A, Evrard A-V, Ivanov VK, Malakhova IV, Kurtinaitis J, Stengrevics A, Teddel M, Anspaugh LR, Bouville A, Chekin S, Chumak VV, Drozdovitch V, Gapanovich V, Golovanov I, Hubert P, Illichev SV, Khait, SE, Kryuchkov VP, Maceika E, Maksyoutov M, Mirkhaidarov AK, Polyakov S, Shchukina N, Tenet V, Tserakovich TI, Tsykalo A, Tukov AR, Cardis C. 2008. Risk of hematological malignancies among Chernobyl liquidators. Radiation Research 170:721-735.
42. Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni JF Jr. 2005. Risk of new cancers following radiotherapy in long-term survivors of retinoblastoma: An extended follow-up. Journal of Clinical Oncology 23:2272-2279.
43. Krestinina LY, Davis F, Ostroumova EV, Epifanova SB, Degteva MO, Preston DL, Akleyev AV. 2007. Solid cancer incidence and low-dose-rate radiation exposures in the Techa River cohort: 1956-2002. International Journal of Epidemiology 36:1038-1046.
44. Krestinina LY, Preston DL, Ostroumova EV, Degteva MO, Ron E, Vyushkova OV, Startsev NV, Kossenko MM, Akleyev AV. 2005. Protracted radiation exposure and cancer mortality in the Techa River cohort. Radiation Research 164(5):602-611.
45. Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, Klotz JB, Letourneau EG, Lynch CF, Lyon JI, Sandler DP, Schoenberg JB, Steck DJ, Stolwijk JA, Weinberg C, Wilcox HB. 2005. Risk of lung cancer in North America associated with residential radon. Epidemiology 16:137-145.
46. Land CE, Hayakawa N, Machado SG, Yamada Y, Pike MC, Akiba S, Tokunaga M. 1994. A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose. Cancer Causes and Control 5:167-176.
47. Land CE, Saku T, Hayashi Y, Takahara O, Matsura H, Tokuoka S, Tokunaga M, Mabuchi K. 1996. Salivary gland tumor incidence among atomic bomb survivors, 1950-87. Evaluation of radiation-related risk. Radiation Research 146:28-36.
48. Linet MS, Freedman DM, Mohan AK, Doody MM, Ron E, Mabuchi K, Alexander BH, Sigurdson A, Hauptmann M. 2005. Incidence of haematopoietic malignancies in US radiologic technologists. Occupational and Environmental Medicine 62:861-867.
49. Little MP. 2001. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors. International Journal of Radiation Biology 77:431-464 and 745-760.
50. Little MP, Weiss HA, Boice JD Jr, Darby SC, Day NE, Muirhead CR. 1999. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis. Radiation Research 152:280-292 and 153:243.
51. Lubin JH, Boice JD Jr, Edling C, Hornung RW, Howe GR, Kunz E, Kusiak RA, Morrison HI, Radford EP, Samet JM, Tirmarche M, Woodward A, Yao SX, Pierce DA. 1995. Lung cancer risk in radon-exposed miners and estimation of risk from indoor exposure. Journal of the National Cancer Institute 87:817-827.
52. Macmahon B, Trichopoulos D. 1996. Epidemiology: Principles and methods. Boston: Little, Brown, and company.
53. Muirhead CR, O'Hagan JA, Haylock RGE, Phillipson MA, Willcock T, Berridge GLC, Zhang W. 2009. Mortality and cancer incidence following occupational radiation exposure: Third analysis of the National Registry for Radiation Workers. British Journal of Cancer 100:206-212.
54. National Council On Radiation Protection and Measurements (NCRP). 2001. Scientific basis for evaluating the risks to populations from space applications of plutonium. NCRP Report No. 131. Bethesda MD: NCRP.
55. National Institutes of Health (NIH). 2003. Report of the NCI-CDC Working Group to revise the 1985 NIH Radioepidemiologic Tables. Bethesda MD: NIH.
56. National Research Council (NRC). 1988. Health risks of radon and other internally deposited alpha-emitters. BEIR IV. Washington, DC: National Academy Press.
57. National Research Council (NRC). 1999. The health effects of exposure to indoor radon. BEIR VI. Washington, DC: National Academy Press.
58. National Research Council (NRC). 2006. Health risks from exposure to low levels of ionizing radiation. BEIR VII - Phase 2. Washington, DC: National Academy Press.
59. Ostroumova E, Gagniere B, Laurier D, Gudkova N, Krestinina L, Verger P, Hubert P, Bard D, Akleyev A, Tirmarche M, Kossenko M. 2006. Risk analysis of lekaemia incidence among people living along the Techa River: A nested case-control study. Journal of Radiological Protection 26:17-32.
60. Ostroumova E, Preston DL, Ron E, Krestinina L, Davis FG, Kossenko M, Akleyev A. 2008. Breast cancer incidence following low-dose rate environmental exposure: Techa River Cohort, 1956-2004. British Journal of Cancer 99:940-1945.
61. Piantadosi S. 1994. Invited commentary: Ecologic biases. American Journal of Epidemiology 139:761-764.
62. Pierce DA, Sharp GB, Mabuchi K. 2003. Joint effects of radiation and smoking on lung cancer risk among atomic bomb survivors. Radiation Research 159:511-520.
63. Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Doby H, Matsuo T, Nonaka H, Thompson DE, Soda M, Mabuchi K. 1994. Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiation Research 137:S68-97.
64. Preston DL, Cullings H, Suyama A, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K, Kasagi F, Shore RE. 2008. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. Journal of the National Cancer Institute 100:428-436.
65. Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JD Jr. 2002b. Radiation effects on breast cancer risk: A pooled analysis of eight cohorts. Radiation Research 158:220-235.
66. Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, Kodama K. 2004. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiation Research 162:377-389.
67. Preston D, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K. 2007. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiation Research 168:1-64.
68. Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuaka S, Mabuch K. 2002a. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. Journal of the National Cancer Institute 94:1555-1563.
69. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. 2003. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiation Research 160:381-407.
70. Richardson DB, Wing S, Schroeder J, Schmitz-Feuerhake I, Hoffmann W. 2005. Ionizing radiation and chronic lympho-cytic leukemia. Environmental Health Perspectives 113:1-5.
71. Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Le FP, Meadows AT, Mulvihill JJ, Neglia JP, Nesbit ME, Packer RJ, Potter JD, Sklar CA, Smith MA, Stovall M, Strong LC, Yasui Y, Zeltzer LK. 2002. Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Medical Pediatric Oncology 38:229-239.
72. Romanenko AY, Finch S, Hatch M, Lubin J, Bebeshko G, Bazyka DA, Gudzenko N, Dyagil IS, Reiss R, Zablotska LB. 2008. The Ukrainian-American study of leukemia and related disorders among cleanup workers from Ukraine: III. Radiation risks. Radiation Research 170:663-672.
73. Ron E. 2003. Cancer risks from medical radiation. Health Physics 85(1):47-59.
74. Ron E, Ikeda T, Preston DL, Tokuoka S. 2005. Male breast cancer incidence among atomic bomb survivors. Journal of the National Cancer Institute 97:603-605.
75. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern L, Schneider AB, Tucker MA, Boice JD. 1995. Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiation Research 141:259-277.
76. Ron E, Preston DL, Kishikawa N, Kobuke T, Iseki M, Tokuoka S, Tokunaga M, Mabuchi K. 1998. Skin tumor risk among atomic-bomb survivors in Japan. Cancer Causes and Control 9:393-401.
77. Ronckers CM, Doody MM, Lonstein JE, Stovall M, Land CE. 2008. Multiple diagnostic x-rays for spine deformities and risk of breast cancer. Cancer Epidemiology and Biomarkers Prevention 17(3):605-613.
78. Schafer DW, Gilbert ES. 2006. Some statistical implications of dose uncertainty in radiation dose-response analyses. Radiation Research 166:303-312.
79. Shilnikova NS, Preston DL, Ron E, Gilbert ES, Vassilenko EK, Romanov SA, Kuznetsova IS, Sokolnikov ME, Okatenko PV, Kreslov VV, Koshurnikova NA. 2003. Cancer mortality risk among workers at the Mayak nuclear complex. Radiation Research 159:787-798.
80. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD. 2005. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study. The Lancet 365:2014-2023.
81. Simon SL, Kleinerman RA, Ron E, Bouville A. 2006a. Uses of dosimetry in radiation epidemiology. Radiation Research 166:125-127. (Entire issue is on 'Applications of Dosimetry in Radiation Epidemiology'.).
82. Simon SL, Weinstock RM, Doody MM, Neton J, Wenzl T, Stewart PA, Mohan AK, Yoder RC, Hauptmann M, Freedman DM, Cardarelli J, Feng HA, Bouville A, Linet M. 2006b. Estimating historical radiation doses to a cohort of U.S. Radiologic Technologists. Radiation Research 166:74-92.
83. Sokolnikov ME, Gilbert ES, Preston DL, Ron E, Shilnikova NS, Kholhryakov VV, Vasilenko EK, Koshurnikova NA. 2008. Lung, liver and bone cancer mortality in Mayak workers. International Journal of Cancer 123:905-911.
84. Stewart A, Webb J, Giles D, Hewitt D. 1956. Malignant disease in childhood and diagnostic irradiation in utero. Lancet 2:447.
85. Stewart AM, Webb KW, Hewitt D. 1958. A survey of childhood malignancies. British Medical Journal 1:1495-1508.
86. Storm HH, Andersson M, Boice JD Jr, Blettner M, Stovall M, Mouridsen HT, Dombernowsky P, Rose C, Jacobsen A, Pedersen M. 1992. Adjuvant radiotherapy and risk of contralateral breast cancer. Journal of the National Cancer Institute 84:1245-1250.
87. Stovall M, Smith SA, Langholz BM, Boice JD Jr, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Rosenstein BS, Reiner AS, Thomas DC, Bernstein JL, WECARE Study Collaborative Group. 2008. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. International Journal of Oncology Biology and Physics 72(4):1021-1030.
88. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Keda T, Terasaki M, Izumi S, Preston DL. 1994. Cancer incidence in atomic bomb survivors. Part II. Solid tumors, 1958-1987. Radiation Research 137:S17-67.
89. Travis LB, Andersson M, Gospodarowicz, van Leeuwen FE, Bergfeldt K, Lynch CF, Curtis RE, Kohler BA, Wiklund T, Storm H, Holowaty E, Hall P, Pukkala E, Sleiffer DT, Clarke EA, Boice JD Jr, Stovall M, Gilbert E. 2000. Treatment-associated leukemia following testicular cancer. Journal of the National Cancer Institute 92:1165-1171.
90. Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni JF Jr, Boice JD Jr, Gilbert E. 2002. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. Journal of the National Cancer Institute 94:182-192.
91. Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklung T, Lynch CF, van't Veer MB, Glimelius I, Storm H, Pukkala E, Stovall M, Curtis R, Boice JD Jr, Gilbert E. 2003. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. Journal of the American Medical Association 290:465-475.
92. Travis LB, Hodgson D, Allan JM, van Leeuwen FE. 2008. Second cancers. In: Devita VT, Lawrence TS, Rosenberg SA, editors. Cancer: Principles and practice of oncology. 8th ed. Philadelphia: Lippincott Williams and Wilkins. pp 2718-2743.
93. Tronko MD, Howe GR, Bogdanova TI, Bouville AC, Epstein OV, Brill AB, Likhtarev A, Fink DF, Markov VV, Greenebaum E, Olijnyk VA, Masnyk IJ, Shpak VM, McConnell J, Tereshschenko P, Robbins J, Zvinchuk OV, Zablotska LB, Hatch M, Luckyanov NK, Ron E, Thomas TL, Voileque PG, Beebe GW. 2006. A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: Thyroid cancer in Ukraine detected during first screening. Journal of the National Cancer Institute 98:897-903.
94. United Nations Scientific Committee on the Effects Of Atomic Radiation (UNSCEAR). 2000. Sources and effects of ionizing radiation. Vol. II: Effects. New York: United Nations.
95. United Nations Scientific Committee on the Effects Of Atomic Radiation (UNSCEAR). 2008. Effects of ionizing radiation. UNSCEAR 2006 report to the General Assembly, with scientific annexes. New York: United Nations.
96. van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, Crommelin MA, Aleman BM, Broeks A, Gospodarowicz M, Travis LB, Russell NS. 2003. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. Journal of the National Cancer Institute 95(13): 971-980.
97. van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeck A, van den Belt-Dusebout AW, Nuyon R, Boice JD Jr, Burgers JM, Somers R. 1995. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. Journal of the National Cancer Institute 87(20):1530-1537.
98. Wakeford R, Little MP. 2003. Risk coefficients for childhood cancer after intrauterine irradiation: A review. International Journal of Radiation Biology 79(5):293-309.
99. Weiss HA, Darby SC, Doll R. 1994. Cancer mortality following x-ray treatment for ankylosing spondylitis. International Journal of Cancer 59(3):327-338.
100. Weiss HA, Darby SC, Fearn T, Doll R. 1995. Leukemia mortality after x-ray treatment for ankylosing spondylitis. Radiation Research 142:1-11.
101. Wong FL, Boice JD Jr, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF Jr, Li FP. 1997. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. Journal of the American Medial Association 278(15):1262-1267.
102. Yoshimoto Y, Delongchamp R, Mabuchi K. 1994. In-utero exposed atomic bomb survivors: Cancer risk update. The Lancet 344:345-346.
103. Yoshinaga S, Hauptmann M, Sigurdson AJ, Doody MM, Freedman DM, Alexander BH, Linet MS, Ron E, Mabuchi K. 2005. Nonmelanoma skin cancer in relation to ionizing radiation exposure among U.S. radiologic technologists. International Journal Cancer 115:828-834.
104. Zabel EW, Alexander BH, Mongin SJ, Doody MM, Sigurnson AJ, Linet MS, Freedman DM, Hauptmann M, Mabuchi K, Ron E. 2006. Thyroid cancer and employment as a radio-logic technologist. International Journal of Cancer 119:1940-1945.